- Noted Biophysicist Brings Expertise in Single Molecule Fluorescence and
Nanoscale Measurement Techniques -
PHILADELPHIA, April 30 /PRNewswire/ -- BioNanomatrix, Inc., a developer of breakthrough nanoscale whole genome imaging platforms for genetic diagnostics, personalized medicine and biomedical research, today announced the appointment of noted biophysicist Paul R. Selvin, Ph.D., to its Scientific Advisory Board (SAB). Dr. Selvin is professor of physics and biophysics and John Bardeen Faculty Scholar at the University of Illinois at Urbana-Champaign.
Dr. Selvin's research focus includes single molecule detection and nanoscale fluorescent measurement. He is the inventor of a widely used nanoimaging technique called FIONA, or Fluorescence Imaging with One Nanometer Accuracy. In 2006, his achievements in developing novel nanoscale tools won him Tel Aviv University's prestigious International Raymond and Beverly Sackler Award for the most outstanding advance in biophysics, noting his pioneering discoveries of fluorescence techniques and his work in single molecule detection and ultra-sensitive instrumentation. Dr. Selvin also was selected for the Biophysical Society's top award for Outstanding Young Investigator in 2004, and he has been the recipient of many other honors.
"Paul has extensive experience in nanotechnology research and development, both as a noted scientific researcher and an inventor of important research tools," said Dr. Han Cao, chief scientific officer and founder of BioNanomatrix. "His work in the area of single molecule imaging is especially relevant to the development of our single molecule whole genome imaging and analysis platform, and we anticipate he will be a valuable contributor as we advance the development of our nanoscale technologies."
Dr. Selvin joined the department of physics at the University of
Illinois in 1997, where he has focused his research efforts on technology
|SOURCE BioNanomatrix, Inc.|
Copyright©2008 PR Newswire.
All rights reserved